• Title: Interview with Dr. Mark C. Rogers, Chairman and CEO of Bradmer Pharmaceuticals
• Artist: Zangani Investor Community(TM)
• Year: 2007
• Length: 3:18 minutes (776.57 KB)
• Format: Mono 22kHz 32Kbps (CBR)

Zangani Investor Community™ interviews Dr. Mark Rogers, Chairman and Chief Executive Officer of Bradmer Pharmaceuticals. Dr. Rogers discusses their upcoming presentation at our Pharma Finance 2007 conference in Rome, Italy on May 10th and 11th and their company business strategy.

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme.